Rekomendasi Jenis Vaksin Covid-19 Untuk Meminimalisir Kejadian Ikutan Pasca Imunisasi (KIPI) Berbasis Mobile
Abstract
The Covid-19 pandemic is one of the events that had an impact on life. Various steps have been taken by the government to prevent the spread. The number of cases that continues to increase makes various policies implemented. One way to do this is by giving the Covid-19 vaccine. Vaccination is still being carried out until the community gets the third dose of the vaccine (booster). Vaccination can give Post Immunization Adverse Events (AEFI). The AEFI experienced can differ from one person to another. Therefore, the Covid-19 vaccine type recommendation system can help to minimize the presence of AEFIs by providing the type of vaccine that is by health conditions.
The Authors submitting a manuscript do so on the understanding that if accepted for publication, copyright of the article shall be assigned to Jurnal Teknologi Informasi dan Terapan (J-TIT) and Department of Information Technology, Politeknik Negeri Jember as publisher of the journal. Copyright encompasses rights to reproduce and deliver the article in all form and media, including reprints, photographs, microfilms, and any other similar reproductions, as well as translations. Authors should sign a copyright transfer agreement when they have approved the final proofs sent by Jurnal Teknologi Informasi dan Terapan (J-TIT) prior to the publication. The copyright transfer agreement can be download here .
Jurnal Teknologi Informasi dan Terapan (J-TIT) and Department of Information Technology, Politeknik Negeri Jember and the Editors make every effort to ensure that no wrong or misleading data, opinions or statements be published in the journal. In any way, the contents of the articles and advertisements published in Jurnal Teknologi Informasi dan Terapan (J-TIT) are the sole responsibility of their respective authors and advertisers.
Users of this website will be licensed to use materials from this website following the Creative Commons Attribution 4.0 International License. No fees charged. Please use the materials accordingly.
This work is licensed under a Creative Commons Attribution-Share A like 4.0 International License
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
